ARA 290 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
84サルコイドーシス2

84. サルコイドーシス


臨床試験数 : 149 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02039687
(ClinicalTrials.gov)
January 201416/1/2014Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With SarcoidosisA Double Blind, Placebo Controlled Phase 2 Dose Ranging Study of the Effects of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With SarcoidosisNeuropathy of SarcoidosisDrug: ARA 290;Other: PlaceboAraim Pharmaceuticals, Inc.NULLCompleted18 Years70 YearsAll64Phase 2United States;Netherlands
2EUCTR2013-003016-45-NL
(EUCTR)
11/09/201315/08/2013study the safety and effects of different doses of ARA 290 administered subcutaneously on the corneal nerve fiber density and symptoms of neuropathic pain in sarcoidosis patients.A double blind, placebo controlled Phase 2 dose ranging study of the effects of ARA 290 on corneal nerve fiber density and neuropathic symptoms of patients with sarcoidosis - DOSARA small fiber neuropathy;Therapeutic area: Body processes [G] - Biological Phenomena [G16]Product Name: ARA 290
Product Code: ARA 290
INN or Proposed INN: ARA 290
Araim PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
64Phase 2United States;Netherlands